Date: 2016-05-10
Type of information: Nomination
Compound:
Company: Opko Health (USA - Fl)
Therapeutic area:
Type agreement: nomination
Action mechanism:
Disease:
Details: * On May 10, 2016, OPKO Health announced the appointment of Thomas Nusbickel as Senior Vice President of Pharmaceutical Marketing and Market Access to support the anticipated launch of Rayaldee®. Mr. Nusbickel has over 25 years of pharmaceutical experience with established large companies, such as Hospira , Amgen and Abbott, with a career long focus on specialty products and nephrology. He has been involved in numerous product launches including serving as the global lead for Amgen's launch of Sensipar, and has deep connections with managed care organizations and with key nephrology opinion leaders. Prior to joining OPKO , Mr. Nusbickel served as Hospira's Head of U.S. Market Access, Biologics and as Amgen's Executive Director, Value Access and Advocacy.
Financial terms:
Latest news:
